Coronary response to diadenosine pentaphosphate after ischaemia-reperfusion in the isolated rat heart

Cardiovascular Research

Volumn 81, Issue 2, 2009, Pages 336-343

  García Villalón, Ángel Luis ^a   Monge, Luis ^a   Fernández, Nuria ^a   Salcedo, Adely ^a   Narváez Sánchez, Raúl ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Coronary circulation; Perfused heart; Purinergic P2x receptors; Purinergic P2y receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CIBACRON BLUE F3GA; DIADENOSINE PENTAPHOSPHATE; MECLOFENAMIC ACID; N(G) NITROARGININE METHYL ESTER; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART RATE; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CORONARY VESSELS; DINUCLEOSIDE PHOSPHATES; MALE; MYOCARDIAL REPERFUSION; NG-NITROARGININE METHYL ESTER; PYRIDOXAL PHOSPHATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; VASOCONSTRICTION;

EID: 58449113543     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvn321     Document Type: Article

References (32)

1. Mclennan AG. Dinucleoside polyphosphates-friend or foe? Pharmacol Ther 2000;87:73-89.
2. Miras-Portugal MT, Gualiz J, Pintor J. The neurotransmitter role of diadenosine polyphosphates. FEBS Lett 1998;430:78-82.
3. Castillo CJ, Moro MA, Del Valle M, Sillero A, Garcia AG, Sillero MA. Diadenosine tetraphosphate is co-released with ATP and catecholamines from bovine adrenal medulla. J Neurochem 1992;59:723-732.
4. Flodggard H, Klenow H. Abundant amounts of diadenosine 5′,5″-P1,P4-tetraphosphate are present and releasable, but metabolically inactive, in human platelets. Biochem J 1982;208:737-742.
5. Steinmetz M, Janssen AK, Pelster F, Rahn KH, Schlatter E. Vasoactivity of diadenosine polyphosphates in human small mesenteric resistance arteries. J Pharmacol Exp Ther 2002;302:787-794.
6. Ralevic V, Hoyle CHV, Burnstock G. Pivotal role of phosphate chain length in vasoconstrictor versus vasodilator actions of adenosine dinucleotides in rat mesenteric arteries. J Physiol 1995;483:703-713.
7. Van der Giet M, Khattab M, Börgel J, Schlüter H, Zidek W. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. Br J Pharmacol 1997;120:1453-1460.
8. Pohl U, Ogilvie A, Lamontagne D, Busse R. Potent effects of Ap3A and Ap4A on coronary resistance and autacoid release of intact rabbit hearts. Am J Physiol 1991;260:H1692-H1697.
9. Stavrou BM, Sheridan DJ, Flores NA. Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates. J Pharmacol Exp Ther 2001;298:531- 538.
10. Sumiyoshi R, Nishimura J, Kawasaki J, Kobayashi S, Takahashi S. Diadenosine polyphosphates directly relax porcine coronary arterial smooth muscle. J Pharmacol Exp Ther 1997;283:548-556.
11. Sugimura A, Kanatsuka H, Tanikawa T, Ong BH, Shirato K. Effect of diadenosine tetraphosphate (Ap4A) on coronary arterial microvessels in the beating canine heart. Jpn Circ J 2000;64:868-875.
12. Flores NA, Stavrou BM, Sheridan DJ. The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res 1999;42:15-26.
13. Climent B, Fernández N, Sanz E, Sánchez A, Monge L, García-Villalón AL et al. Enhanced response of pig coronary arteries to endothelin-1 after ischemia-reperfusion. Role of endothelin receptors, nitric oxide and prostanoids. Eur J Pharmacol 2005;524:102-110.
14. Climent B, Fernández N, García-Villalón AL, Monge L, Sánchez A et al. Effects of antagonists for ETA and ETB receptors on coronary endothelial and myocardial function after ischemia-reperfusion in anaesthetized goats. Vasc Parmacol 2006;44:384-390.
15. Reffelmann T, Kloner RA. Microvascular alterations after temporary coronary occlusion: the no-reflow phenomenon. J Cardiovasc Pharmacol Ther 2004;9:163-172.
16. Gawaz M. Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res 2004;61:498-511.
17. Kitakaze M, Sekine A, Yamaura T, Nakajima H, Hori M. A novel endogenous vasoactive substance, diadenosine tetraphosphate (Ap4A), produced in the ischemic heart as a new vasodilatory mediator. Abstract. Circulation 1995;92(Suppl. I):38.
18. Stavrou BM, Beck C, Flores NA. Changes in extracellular pH and myocardial ischemia alter the cardiac effects of diadenosine tetraphosphate and pentaphosphate. Br J Pharmacol 2001;134:639-647.
19. Jovanovic A, Jovanovic S, Mays DC, Lipsky JJ, Terzic A. Diadenosine 5′,5″ P1,P5-pentaphosphate harbors the properties of a signalling molecule in the heart. FEBS Lett 1998;423:314-318.
20. García-Villalón AL, Sanz E, Monge L, Fernández N, Climent B et al. Urocortin protects coronary endotelial function during ischemia-reperfusion: a brief communication. Exp Biol Med 2004;229:118-120.
21. Steinmetz M, Gabriëls G, Van Le T, Piechota H-J, Rahn KH, Schlatter E. Vasoactivity of diadenosine polyphosphates in human renal resistance arteries. Nephrol Dial Transplant 2003;18:2496-2504.
22. Steinmetz M, Schlatter E, Boudier HA, Rahn KH, De Mey JG. Diadenosine polyphosphates cause contraction and relaxation in isolated rat resistance arteries. J Pharmacol Exp Ther 2000;294:1175-1181.
23. Gabriëls G, Rahan KH, Schlatter E, Steinmetz M. Mesenteric and renal vascular effects of diadenosine polyphosphates (APnP). Cardiovasc Res 2002;56:22-32.
24. Neumann J, Meissner A, Boknik P, Gombosová I, Knapp J, Lüss H et al. Inotropic effects of diadenosine tetraphosphate in isolated canine cardiac preparations. J Cardiovasc Pharmacol 1999;33:151- 156.
25. Vahlensieck U, Boknic P, Gombosová I, Huke S, Knapp J, Linck B et al. Inotropic effects of diadenosine tetraphosphate (Ap4A) in human and animal cardiac preparations. J Pharmacol Exp Ther 1999;288:805-813.
26. Hoyle CHV, Ziganshin AU, Pintor J, Burnstock G. The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates. Br J Pharmacol 1996;118:1294-1300.
27. Jovanovic A, Alekseev AE, Terzic A. Cardiac ATP-sensitive K+ channel: a target for diadenosine 5′,5″-P1,P5-pentaphosphate. Naunyn-Schmiedeberg's Arch Pharmacol 1996;353:241-244.
28. Elvir-Mairena JR, Jovanovic A, Gomez LA, Alekseev AE, Terzic A. Reversal of ATP-liganded state of ATP-sensitive K+ channels by adenylate kinase activity. J Biol Chem 1996;271:31903-31908.
29. Gerevich Z, Zadori Z, Müller C, Wirkner K, Schröder W, Rubini P et al. Metabotropic P2Y receptors inhibit P2X3 receptor channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol 2007;151:226-236.
30. Sokolova E, Skorinkin A, Fabbretti E, Masten L, Nistri A, Giniatullin R. Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel sensitive approach for their rapid up or downregulation. Br J Pharmacol 2004;141:1048-1058.
31. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 2004;61:402-413.
32. Dieguez G, Martínez MA, Fernández N, Climent B, García-Villalón AL et al. Vasopressin effects on the coronary circulation after a short ischemia in anesthetized goats. Role of nitric oxide and prostanoids. Eur J Pharmacol 2004;495:171-177.